top of page

Aries Biotech is Expanding!


Aries Biotech is pleased to announce new hours of operation!

Effective 01 October 2022, hours of operation will be Monday-Thursday, 8am to 6pm (PST) by appointment. This change will help to accommodate increased interest across neuroscience and neurotrauma R&D, product development, novel concepts, and data dissemination.


Visit our Website to make an appointment



Aries Biotech specializes in providing neurological disease and dementia biomarker consulting services. We are dedicated to meeting your specific needs and requirements. Discover how we can enhance your projects by visiting Aries Biotech at:

21 views0 comments

Recent Posts

See All

Dr. Boutte Joins PRECISE-TBI Biomarker Working Group

Dr. Boutte Joins PRECISE-TBI Biomarker Working Group Aries Biotech extends gratitude to the PRECISE-TBI team, for inviting Dr. Angela Boutte, the founder of Aries Biotech, to participate in the precli

Dr. Boutte of Aries Biotech Consults for BBCETC

Dr. Boutte of Aries Biotech is honored to serve as a consultant for BBC Entrepreneurial Training & Consulting (BBCetc).  The BBCetc (https://bbcetc.com/) is nationally recognized for successfully help

Thank you - Alzheimer’s Research UK!

Aries Biotech extends gratitude to the Alzheimer’s Research UK team, for inviting Dr. Angela Boutte, the founder of Aries Biotech, as a contributing reviewer and panelist. Through partnerships with th

Comments


bottom of page